Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Other Non-Current Assets: 2011-2024

Historic Other Non-Current Assets for Iovance Biotherapeutics (IOVA) over the last 5 years, with Dec 2024 value amounting to $6.4 million.

  • Iovance Biotherapeutics' Other Non-Current Assets was N/A to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2024, which is 90.43% down from last year.
  • As of FY2024, Iovance Biotherapeutics' Other Non-Current Assets stood at $6.4 million, which was down 90.43% from $66.4 million recorded in FY2023.
  • Iovance Biotherapeutics' Other Non-Current Assets' 5-year high stood at $66.4 million during FY2023, with a 5-year trough of $6.4 million in FY2024.
  • In the last 2 years, Iovance Biotherapeutics' Other Non-Current Assets had a median value of $36.4 million in 2023 and averaged $36.4 million.
  • Data for Iovance Biotherapeutics' Other Non-Current Assets shows a maximum YoY plummeted of 90.43% (in 2024) over the last 5 years.
  • Over the past 2 years, Iovance Biotherapeutics' Other Non-Current Assets (Yearly) stood at $66.4 million in 2023, then plummeted by 90.43% to $6.4 million in 2024.